|
About WaveSense
What We Do: WaveSense
develops, manufactures, and markets breakthrough analytical
nanotechnologies for use in cellular and molecular assay markets.
Some of the applications that we are actively engaged in consist
of drug discovery, rare cell detection in blood and bone marrow,
nucleic acid tests for infectious disease, bio-defense, veterinary
diagnostics, and regenerative medicine.
Our Proprietary Technology:
Our patented and hierarchy technology is called Xenographic
Retention Chromatography™ (XRC) - branded as EpiSep™,
which is a lateral flow separations platform that provides
rapid, advanced detection and characterization of live cells,
proteins, and/or genes. Researchers can then harvest the targets
for interrogation purposes within their desired application.
Our Value Proposition:
We developed EpiSep™ because current assays that detect
rare targets are outgrowing the capabilities and efficiencies
of platforms that are commonly used to perform these tests.
Our EpiSep™ platform, and extensive line of leading-edge
assays, are revolutionary to the analytical industry as they
fulfill a critical demand to significantly improve test sensitivity
and workflow procedures, while reducing operational costs
and complexity.
Users of Our Products:
End users of our products consist of reference laboratories,
pathologists, and researchers that perform a wide variety
of analytical tests for research purposes.
Why We Do This:
We strive to improve the quality and length of life by discovering
and applying leading-edge nanotechnologies to life science
research. We adopt this approach with an added interest to
create value for our employees and shareholders.
Our Background:
WaveSense is a privately held California company that was
founded in 1999 by Christopher Feistel and Robert Coleman.
Individually and collectively, Feistel and Coleman have participated
as principal inventor, co-founder, chairman, president and/or
CEO of more than 10 medical device companies resulting in
successful organizations with combined valuations exceeding
one billion dollars.
Our Facility -
Our corporate offices and laboratory are housed in an 8500
Square Foot facility located at 15339 Barranca Parkway, Irvine,
CA 92618.
Thank you for visiting our web site.
|
